2017-03-01Zeitschriftenartikel
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
Phase IIb study protocol
Doorn, Eva van; Liu, Heng; Ben-Yedidia, Tamar; Hassin, Shimon; Visontai, Ildiko; Norley, Stephen; Frijlink, Henderik W.; Hak, Eelko
Introduction: Influenza is a major respiratory viral infection of humans with high mortality and morbidity rates and profound economic impact. Although influenza vaccines are generally updated yearly to match the viruses ...